Meeting Abstract
BibTex RIS Cite

INVESTIGATION OF THE ANTIMETASTATIC POTENTIAL OF T. SPICATA IN HUMAN BREAST ADENOCARCINOMA CELLS COMBINED WITH STANDARD CHEMOTHERAPY

Year 2022, , 62 - 62, 09.08.2022
https://doi.org/10.26650/JARHS2021-1145563

Abstract

Objective: The aim of this study was to determine the effects of hexane extract prepared from Thymbra spicata (TS) on the cytotoxic, antioxidant and metastatic process in human breast adenocarcinoma cell lines (MDA-MB-231, BT-474) in combination with the chemotherapeutic drug Paclitaxel (PAC). Materials And Methods: IC25 and IC50 concentrations of TS and PAC in MDA-MB-231 and BT-474 cell lines were determined by the modified MTT method we developed in our laboratory. Cell motility as an indicator of metastatic potential was evaluated by in vitro wound healing method. MDA was evaluated in cellular cytotoxicity in MB 231 by TAS and TOS analyses. Results: IC25 and IC50 concentrations of TS and PAC in MDA MB 231 and BT-474 cell lines were determined by the modified MTT method we developed in our laboratory. Cell motility as an indicator of metastatic potential was evaluated by in vitro wound healing method. MDA was evaluated in cellular cytotoxicity in MB 231 by TAS and TOS analyses. In wound healing experiments where migration and invasion were tested: MDA MB 231; There was no statistically significant difference in the effect of PAC and TS25/PAC25 doses on cell migration. BT-474; TS and TS25/PAC25 doses were found to be effective in stopping cell migration. Conclusion: The findings revealed the prediction that TS may be among the candidate agents in terms of giving as supportive treatment.

References

  • Arayıcı ME YF, Ellidokuz H. Importance of Cancer Registration and its Place in Cancer Control. Sted. 2021;30(5):366-75.

INVESTIGATION OF THE ANTIMETASTATIC POTENTIAL OF T. SPICATA IN HUMAN BREAST ADENOCARCINOMA CELLS COMBINED WITH STANDARD CHEMOTHERAPY

Year 2022, , 62 - 62, 09.08.2022
https://doi.org/10.26650/JARHS2021-1145563

Abstract

Objective: The aim of this study was to determine the effects of hexane extract prepared from Thymbra spicata (TS) on the cytotoxic, antioxidant and
metastatic process in human breast adenocarcinoma cell lines (MDA-MB-231, BT-474) in combination with the chemotherapeutic drug Paclitaxel (PAC).
Materials And Methods: IC25 and IC50 concentrations of TS and PAC in MDA-MB-231 and BT-474 cell lines were determined by the modified MTT method
we developed in our laboratory. Cell motility as an indicator of metastatic potential was evaluated by in vitro wound healing method. MDA was evaluated
in cellular cytotoxicity in MB 231 by TAS and TOS analyses.
Results: IC25 and IC50 concentrations of TS and PAC in MDA MB 231 and BT-474 cell lines were determined by the modified MTT method we developed
in our laboratory. Cell motility as an indicator of metastatic potential was evaluated by in vitro wound healing method. MDA was evaluated in cellular
cytotoxicity in MB 231 by TAS and TOS analyses.
In wound healing experiments where migration and invasion were tested: MDA MB 231; There was no statistically significant difference in the effect of
PAC and TS25/PAC25 doses on cell migration. BT-474; TS and TS25/PAC25 doses were found to be effective in stopping cell migration.
Conclusion: The findings revealed the prediction that TS may be among the candidate agents in terms of giving as supportive treatment.

References

  • Arayıcı ME YF, Ellidokuz H. Importance of Cancer Registration and its Place in Cancer Control. Sted. 2021;30(5):366-75.
There are 1 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Meeting Abstract
Authors

Tarık Salman 0000-0001-7911-6978

Arzu Yıldırım 0000-0003-2027-5426

Yağmur Kaya 0000-0002-6448-373X

Hılal Kocdor This is me 0000-0002-6935-3993

Publication Date August 9, 2022
Submission Date July 19, 2022
Published in Issue Year 2022

Cite

MLA Salman, Tarık et al. “INVESTIGATION OF THE ANTIMETASTATIC POTENTIAL OF T. SPICATA IN HUMAN BREAST ADENOCARCINOMA CELLS COMBINED WITH STANDARD CHEMOTHERAPY”. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 5, no. S-1, 2022, pp. 62-62, doi:10.26650/JARHS2021-1145563.